Fig. 3From: Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniquesKaplan Meier analysis of Her2/neu gene status in bladder cancer. Disease-specific Survival (DSS) outcome for patients according to their Her2/neu gene amplification status (p < 0.02, log-rank test)Back to article page